Investor mix
5 investors on record; lead investors include Viva Biotech.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 60% |
| Other / undisclosed | 2 | 40% |
Developer of GPCR drugs for the non-opioid treatment of pain
5 investors on record; lead investors include Viva Biotech.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 60% |
| Other / undisclosed | 2 | 40% |